Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company’s microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a diverse set of human conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions. Federation Bio’s lead program is in secondary hyperoxaluria, a serious renal condition that affects more than 200,000 Americans and for which there are currently no approved therapies. Additional information can be found at www.federation.bio
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $50M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Altitude L... | altitudels... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.10.2020 | Series A | $50M | - |
Mentions in press and media 5
| Date | Title | Description |
| 08.01.2021 | Venrock’s Bryan Roberts on the firm’s new $450 million fund, and where it’s shopping in 2021 | Venrock, the 51-year-old firm that started as the venture arm of the Rockefeller family, has closed its ninth fund with $450 million, the same amount it raised for its last two funds. The outfit, with offices in Palo Alto, New York and Camb... |
| 09.10.2020 | Microbial Therapy Company Federation Bio Raises $50 Million | Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role — announced that it has raised $50 million in a Series A round of funding Federation Bio — a microbial therapeutics ... |
| 07.10.2020 | Federation Bio Raises $50M in Series A Financing | Federation Bio, a South San Francisco, CA-based microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, closed a $50m Series A financing. Horizons Ventures led the Series A financing, joined... |
| 06.10.2020 | The Crunchbase News Briefing: Tue., Oct. 6 | 5 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know. Subscribe to the Crunchbase Daily Ÿnsect raises $224M ... |
| 06.10.2020 | Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies |